Growth Metrics

Celularity (CELU) Shares Outstanding (Weighted Average) (2020 - 2025)

Celularity has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $17.1 million for Q3 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $17.1 million for Q3 2025, up 56.47% from a year ago — trailing twelve months through Sep 2025 was $17.1 million (up 56.47% YoY), and the annual figure for FY2024 was $21.9 million, up 22.89%.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $17.1 million at Celularity, down from $23.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for CELU hit a ceiling of $173.5 million in Q3 2023 and a floor of $10.1 million in Q1 2025.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $23.8 million (2025), compared with a mean of $52.3 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): soared 463.97% in 2022 and later plummeted 93.72% in 2024.
  • Celularity's Shares Outstanding (Weighted Average) stood at $67.1 million in 2021, then crashed by 79.14% to $14.0 million in 2022, then increased by 27.32% to $17.8 million in 2023, then grew by 22.89% to $21.9 million in 2024, then decreased by 22.05% to $17.1 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $17.1 million (Q3 2025), $23.8 million (Q2 2025), and $10.1 million (Q1 2025) per Business Quant data.